Animal Health Investment Europe is a premier international investment forum. The event was held on February 26th and 27th in London. More than 60 companies applied to participate in the Showcase, but only 24 were finalists, among whom was ALGENEX.
The finalists, hand-picked by the Selection Committee, introduced themselves and their products/services on the main stage, in a quick-fire round of presentations.
Claudia JimÃ©nez, General Manager of ALGENEX, explained the CrisBioÂ® technology, which consists in natural bio-reactors which have unique advantages for industrial production of any kind of recombinant protein, offering the most simple, cost-effective and scalable production technology up to date. CrisBioÂ®Â has multiple advantages to obtain biotechnological high-tech products, with respect to classical production based on bioreactors.